Data Presented at American Academy of Dermatology Shows Significant Improvement in Moderate-to-Severe Nail Psoriasis with No New Safety Signals PRINCETON, N.J., March 7, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries, Inc., USA, a wholly owned subsidiary of Sun Pharmaceutical...
Read More Details
Finally We wish PressBee provided you with enough information of ( ILUMYA® (tildrakizumab-asmn) Found Effective for Treatment of Moderate-to-Severe Plaque Psoriasis Affecting Nails in Study Presented at 2025 AAD Conference )
Also on site :
- Possible tornado in Phelps on Monday
- Evacuations ordered after brush fire breaks out in Laguna Beach
- Photos: A blaze at Cairo telecommunications building causes service disruptions